Physician profile
Peter Corey Mandel
NPI 1730259094
$2,654.02
in general payments reported to CMS, 2019-2025
24 companies · $228 in 2025
The $228 reported for 2025 was more than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $482 · 2020: $84.38 · 2021: $80.10 · 2023: $1,681 · 2024: $98.29 · 2025: $228.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $1,389 · Food and Beverage: $519 · Education: $99.99.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $1,389.14 |
| Food and Beverage | $518.70 |
| Education | $99.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $1,451.36 | 2023 | Da Vinci Surgical System |
| Astellas Pharma US INC | $230.13 | 2019-2025 | Veozah |
| Abbvie INC. | $123.60 | 2019-2023 | |
| Vertical Pharmaceuticals, LLC | $86.84 | 2019-2020 | |
| Pfizer INC. | $86.45 | 2019-2023 | |
| Radius Health, INC. | $84.11 | 2023-2025 | |
| Bayer Healthcare Pharmaceuticals INC. | $74.22 | 2019-2020 | |
| Exact Sciences Corporation | $66.78 | 2025 | Cologuard Collection Kit |
| Sumitomo Pharma America, INC. | $50.69 | 2024-2025 | Myfembree |
| Mayne Pharma Commercial LLC | $48.53 | 2023-2025 | |
| Exeltis, USA INC. | $47.08 | 2019-2024 | Slynd |
| Hologic Sales and Service, LLC | $44.88 | 2021 | |
| Minerva Surgical, INC | $41.47 | 2021-2023 | |
| Allergan, INC. | $40.37 | 2019 | |
| Millicent US INC | $35.80 | 2019-2020 |
Show all 24 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Davol INC. | $27.89 | 2019 | |
| Olympus America INC. | $18.50 | 2019 | |
| Sandoz INC. | $15.68 | 2025 | Jubbonti |
| Lupin INC. | $15.38 | 2019 | |
| Meditrina | $14.25 | 2025 | |
| Becton, Dickinson and Company | $13.22 | 2019 | |
| Coopersurgical, INC. | $12.52 | 2020 | |
| Roche Diagnostics Corporation | $12.30 | 2021 | |
| Therapeuticsmd, INC. | $11.97 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Peter Mandel listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.